1. Exploring the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Glycyrrhizic and Glycyrrhetinic Acids
   Seidu A. Richard et al, 2021, Mediators of Inflammation CrossRef
2. Cisplatin cycles treatment sustains cardiovascular and renal damage involving TLR4 and NLRP3 pathways
   Antonio González et al, 2023, Pharmacology Research & Perspectives CrossRef
3. Nebulized glycyrrhizin/enoxolone drug modulates IL-17A in COVID-19 patients: a randomized clinical trial
   Ulises Zendejas-Hernandez et al, 2024, Frontiers in Immunology CrossRef